Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
307-04-006 ISMRM Abstract

Identifying Non-ischemic HFrEF Patients for Cardiac Resynchronization Therapy Beyond Current Guidelines: Insights from Cardia

Primary: Cardiovascular - Arrhythmia
Secondary: Cardiovascular - Myocardium
307-04-006 · Heart Failure · Monday, 11 May, 4:10 PM–6:00 PM · Meeting Room 1.40
Keywords: Arrhythmia Cardiac MRI Cardiac function Clinical Decision-Making Cardiac Motion
Accepted
Di Zhou 1, Minjie Lu1,2, Jing An3
1Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
2Fuwai Hospital, Beijing, China
3Magnetic resonance, Siemens Shenzhen Magnetic Resonance Ltd., Shenzhen, China
Presenting Author: Di Zhou

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79: e263-e421.
2. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42: 3599-3726.
3. Wilkoff BL, Filippatos G, Leclercq C, et al. Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial. Lancet. 2023;402: 1147-1157.
4. Kawata H, Bao H, Curtis JP, et al. Cardiac Resynchronization Defibrillator Therapy for Nonspecific Intraventricular Conduction Delay Versus Right Bundle Branch Block. J Am Coll Cardiol. 2019;73: 3082-3099.
5. Auricchio AFaletra FF. Use of Contemporary Imaging Techniques for Electrophysiological and Device Implantation Procedures. JACC Cardiovasc Imaging. 2020;13: 851-865.
6. Aalen JM, Donal E, Larsen CK, et al. Imaging predictors of response to cardiac resynchronization therapy: left ventricular work asymmetry by echocardiography and septal viability by cardiac magnetic resonance. Eur Heart J. 2020;41: 3813-3823.
7. Taylor RJ, Umar F, Lin EL, et al. Mechanical effects of left ventricular midwall fibrosis in non-ischemic cardiomyopathy. J Cardiovasc Magn Reson. 2016;18: 1.
8. Kowallick JT, Morton G, Lamata P, et al. Quantitative assessment of left ventricular mechanical dyssynchrony using cine cardiovascular magnetic resonance imaging: Inter-study reproducibility. JRSM Cardiovasc Dis. 2017;6: 2048004017710142.
9. Parsai C, Bijnens B, Sutherland GR, et al. Toward understanding response to cardiac resynchronization therapy: left ventricular dyssynchrony is only one of multiple mechanisms. Eur Heart J. 2009;30: 940-9.
10. Bilchick KC, Dimaano V, Wu KC, et al. Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy. JACC Cardiovasc Imaging. 2008;1: 561-8.

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/307-04-006